GENEGENETIC TECHNOLOGIES LTD

Nasdaq genetype.com


$ 0.89 $ 0.00 (0.12 %)    

Wednesday, 21-Aug-2024 15:59:59 EDT
QQQ $ 474.21 $ -2.53 (-0.53 %)
DIA $ 413.38 $ 0.75 (0.18 %)
SPY $ 560.98 $ -0.18 (-0.03 %)
TLT $ 97.97 $ -0.04 (-0.04 %)
GLD $ 231.57 $ -0.24 (-0.11 %)
$ 0.9261
$ 0.78 x 100
$ 0.93 x 4,000
-- - --
$ 0.69 - $ 23.25
5,533
na
712,582
$ 1.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 genetic-technologies-transitions-to-a-capital-light-operating-model-with-lower-cost-operations-continued-focus-on-the-cos-core-business-of-easydna-and-genetype-working-capital-funded-by-short-term-800000-secured-loan-active-channel-partners-in-the-usa-with-genetype-sales-growth-easydna-sales-of-7m-and-growing

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GENE")), a global leader in genomics-based te...

 genetic-technologies-appoints-mark-ziirsen-as-chief-financial-officer

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetype-announces-the-introduction-of-suite-of-genetic-risk-assessment-tests-to-canada-and-new-zealand

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION